There are many monoclonal antibodies for which the hybridoma cell line is unavailable. To complement our hybridoma sequencing service, we are also offering a de novo antibody protein sequencing service.
By combining mass-spectrometry with high-accuracy de novo peptide sequencing and assembly of overlapping peptides, the amino acid sequences of the variable domains are determined.
We guarantee to deliver a functional antibody sequence along with a comprehensive sequencing report with full sequence coverage. In combination with our transient expression service, we can sequence an antibody and deliver recombinant versions in as little as 9 weeks.
The whole combined service is priced at 11,550 GBP / 15,000 USD / 13,180 EUR. For more information please get in touch.
|Customer provides||Mass Spectrometric Sequencing||Antibody Expression||Timeline||Deliverables|
|Monoclonal antibody, >0.2 mg, 95% pure||9 weeks|